Pancreatic Cancer Research

ResearcherGerman Cancer Research CenterNo recent work listed

Thomas G. Hofmann

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0547-2720; OpenAlex author ID A5006689481. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper

Papers 2

  1. Pancreatic Ductal Adenocarcinoma (PDAC) Organoids: The Shining Light at the End of the Tunnel for Drug Response Prediction and Personalized Medicine. First author DOI 10.3390/cancers12102750↗
  2. Transcriptional co-factor Transducin beta-like (TBL) 1 acts as a checkpoint in pancreatic cancer malignancy. Co-author DOI 10.15252/emmm.201404837↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Pierre‐Olivier Frappart · 1 shared paper, 2020 · strength 0.24
  2. Christian Stoy · 1 shared paper, 2015 · strength 0.04
  3. Andrea S. Bauer · 1 shared paper, 2015 · strength 0.04
  4. Matthias M. Gaida · 1 shared paper, 2015 · strength 0.04
  5. Stephan Herzig · 1 shared paper, 2015 · strength 0.04
  6. Oliver Strobel · 1 shared paper, 2015 · strength 0.04
  7. Jörg D. Hoheisel · 1 shared paper, 2015 · strength 0.04
  8. Jens Werner · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.